Aimmune Therapeutics' Series B Round

Aimmune Therapeutics raised a round of funding on March 12, 2015.

Aimmune Therapeutics, formerly, Allergen Research Corporation (ARC), is developing treatments for food allergies using standardized, pharmaceutical-grade food allergens and characterized oral desensit…

Articles about Aimmune Therapeutics' Series B Round: